| |
|
|
|
Alpine Immune Sciences Inc  
|
|
3.98 0.09 (0.02%) |
06-05 12:15 |
|
Open: |
3.95 |
Pre close: |
3.89 |
Target:
|
4.79
|
|
High: |
4.1 |
Low: |
3.95 |
Resistance:
|
4.10
4.79
|
|
Volume: |
28,682 |
Market Cap: |
74M |
Support:
|
3.16
2.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.98
 |
MACD |
MACD(12,26):
|
0.25 |
|
MA(20): |
3.48 |
Signal(12,26,9): |
0.19 |
|
MA(100): |
3.10  |
Stochastic Oscillator |
%K(14,3):
|
91.03 |
|
MA(250): |
3.50 |
%D(3): |
92.37 |
|
Average Volume(K) |
3-Month: |
1880
|
52-Week |
High:
|
5.35 |
|
10-Days: |
3150 |
Low: |
2.05 |
|
RSI |
RSI(14):
|
66.35 |
Change(%): |
-7.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.883 |
Return on Equity (ttm) |
-86.0 |
Shares Out. (M) |
18.59 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-39.0 |
Shares Float (M) |
3.96 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
40.52 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
44.39 |
|
Forward EPS |
-2.280 |
Gross Profit (p.s.) |
-1.835 |
Shares Short (K) |
6 |
|
Book Value (p.s.) |
1.340 |
EBITDA (p.s.) |
-1.945 |
P/E |
-2.13 |
|
Sales Per Share |
0.152 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.99 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-33.82 |
P/S |
26.34 |
|
Operating Margin |
-1287.32 |
Levered Free Cash Flow
(M) |
-24.42 |
P/CF |
-2.20 |
|
|
|
|
|
|
